Literature DB >> 6966938

Identification of T and B lymphocytes in the human conjunctiva and lacrimal gland in ocular diseases.

R Belfort, N F Mendes.   

Abstract

The presence and localisation of T and B lymphocytes in biopsy specimens of human conjunctiva and lacrimal gland from 34 patients were studied in frozen sections. Eighteen patients had follicular conjunctivitis, 13 patients had Sjögren's syndrome, and 3 were normal. All cases of follicular conjunctivitis showed a similar picture. B cells were in higher number than T cells, but both types of lymphocytes were present in the infiltrates. In the developed follicles T cells occupied the periphery and B cells the central part of the infiltrates. In patients with Sjögren's syndrome the conjunctival biopsies showed a higher number of B lymphocytes. The number of T cells was higher in the lesions from Sjögren's syndrome than in cases of follicular conjunctivitis. The infiltrate in lacrimal gland biopsies showed T cells which were scattered while B cells were more numerous and formed clusters close to vessels. Normal conjunctiva and lacrimal gland showed no adherence of either sheep erythrocytes or human erythrocytes sensitised with antibody and complement.

Entities:  

Mesh:

Year:  1980        PMID: 6966938      PMCID: PMC1039390          DOI: 10.1136/bjo.64.3.217

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

Review 1.  Immunological identification of human lymphoid cell populations.

Authors:  N F Mendes
Journal:  Lymphology       Date:  1977-06       Impact factor: 1.286

2.  Combined detection of human T and B lymphocytes by rosette formation with sheep erythrocytes and zymosan-C3 complexes.

Authors:  N F Mendes; S S Miki; Z F Peixinho
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

3.  T and B lymphocytes in patients with lepromatous leprosy.

Authors:  N F Mendes; S Kopersztych; N G Mota
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

4.  Tissue localization of two populations of human lymphocytes distinguished by membrane receptors.

Authors:  N P Silveira; N F Mendes; M E Tolnai
Journal:  J Immunol       Date:  1972-05       Impact factor: 5.422

Review 5.  Clinical applications of T, B, and K cell determinations in rheumatic diseases: a review.

Authors:  M A Scheinberg; N F Mendes; S Kopersztych; E S Cathcart
Journal:  Semin Arthritis Rheum       Date:  1976-08       Impact factor: 5.532

6.  Rosétte formation between human b lymphocytes and zymosan-C3 complexes using different complement sources.

Authors:  A A Kajdacsy-Balla; N F Mendes
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

7.  A receptor for the third component of complement in the human renal glomerulus.

Authors:  M C Gelfand; M M Frank; I Green
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

  7 in total
  4 in total

1.  Suppression of lymphocyte proliferation and regulation of dendritic cell phenotype by soluble mediators from rat lacrimal epithelial cells.

Authors:  M de Saint Jean; T Nakamura; Y Wang; M D Trousdale; J E Schechter; A K Mircheff
Journal:  Scand J Immunol       Date:  2009-07       Impact factor: 3.487

Review 2.  Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome.

Authors:  Amrita Srivastava; Helen P Makarenkova
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

3.  The Effects of Lycium chinense, Cuscuta chinensis, Senna tora, Ophiopogon japonicus, and Dendrobium nobile Decoction on a Dry Eye Mouse Model.

Authors:  Cheng-Chan Yang; Jia-Ying Chien; Yu-Yau Chou; Jhih-Wei Ciou; Shun-Ping Huang
Journal:  Medicina (Kaunas)       Date:  2022-08-21       Impact factor: 2.948

4.  Disease-Specific Expression of Conjunctiva Associated Lymphoid Tissue (CALT) in Mouse Models of Dry Eye Disease and Ocular Allergy.

Authors:  Philipp Steven; Sebastian Schwab; Anne Kiesewetter; Daniel R Saban; Michael E Stern; Uta Gehlsen
Journal:  Int J Mol Sci       Date:  2020-10-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.